NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
6.24
+0.16 (2.63%)
At close: Aug 13, 2025, 4:00 PM
6.24
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:42 AM EDT
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$313,268
Profits / Employee
-$47,290
Market Cap
806.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEO News
- 1 day ago - Neo Performance Materials Inc. (NOPMF) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 15 days ago - NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy - Business Wire
- 15 days ago - NeoGenomics, Inc. (NEO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - NeoGenomics Reports Second Quarter 2025 Results - Business Wire
- 6 weeks ago - NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 - Business Wire
- 6 weeks ago - NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care - Business Wire
- 7 weeks ago - NeoGenomics Appoints Dr. Marjorie Green to Board of Directors - Business Wire
- 2 months ago - NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 - Business Wire